ERS International Congress 2021: highlights from the Clinical Techniques, Imaging and Endoscopy Assembly.

This article summarises the highlights from the European Respiratory Society's "Clinical techniques, imaging and endoscopy" Assembly 14 presented at the virtual 2021 European Respiratory Society International Congress. Cutting-edge innovative developments in both diagnostic approaches and therapeutic strategies in patients with lung cancer, interstitial lung disease, obstructive airway disorders and infectious diseases were presented on this year's interactive congress platform. In this article, the Assembly 14 subgroups summarise the key take home messages given new research outcomes and place them in the context of the current knowledge.

Informations de copyright

Copyright ©The authors 2022.

Déclaration de conflit d'intérêts

Conflict of interest: C. Bal has nothing to disclose. Conflict of interest: C. Falster reports a fee for a lecture at a professional meeting organised by AstraZeneca outside the submitted work. Conflict of interest: A. Carvalho reports lecture fees from Zambon and Boehringer Ingelheim outside the submitted work. Conflict of interest: N. Hersch has nothing to disclose. Conflict of Interest: J. Brock reports lecture fees and consulting activity from Boehringer Ingelheim, Streamed up! and AstraZeneca outside the submitted work. Conflict of interest: J. Brock reports lecture fees and consulting activity from Boehringer Ingelheim, Streamed up! and AstraZeneca outside the submitted work. C.B. Laursen reports a fee for a lecture at a research symposium organised by AstraZeneca outside the submitted work. Conflict of interest: S. Walsh reports fees for lectures at research symposiums organised by Zambon and Boehringer Ingelheim outside the submitted work. Conflict of interest: J. Annema reports research grants from Boston Scientific and Maunea Kea outside the submitted work. Conflict of interest: D. Gompelmann reports lecture and travel fees from Pulmonx, AstraZeneca, Boehringer Ingelheim, Olympus, Chiesi, Berlin Chemie and Novartis outside the submitted work.